Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Topical Cyclosporine vs. Placebo for Epiphora Associated With Docetaxel
This study is currently recruiting participants.
Study NCT00824811 Information provided by M.D. Anderson Cancer Center
First Received: January 16, 2009 Last Updated: June 19, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Epiphora
Additional conditions recognized in this trial
Lacrimal Apparatus Diseases
More general conditions related to this trial
Eye Diseases
Interventions listed in this trial
Cyclosporine Eye Drops (Restasis)
Additional drug interventions recognized in this trial
Cyclosporine
Cyclosporins
Docetaxel
Fluorometholone
Tetrahydrozoline
More general drug interventions related to this trial
Anti-Allergic Agents
Anti-Infective Agents
Anti-Inflammatory Agents
Antifungal Agents
Antineoplastic Agents
Antirheumatic Agents
Autonomic Agents
Cardiovascular Agents
Dermatologic Agents
Enzyme Inhibitors
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Nasal Decongestants
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Sympathomimetics
Therapeutic Uses
Vasoconstrictor Agents
Sponsors listed in this trial
M.D. Anderson Cancer Center
Allergan
Back to top of Main Content
